FDA NDC Directory · JSON-LD · Markdown

Atomoxetine

NDC 0093-3545 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerTeva Pharmaceuticals USA, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA079022
Dosage form / routeCAPSULE · ORAL
Active ingredientsATOMOXETINE HYDROCHLORIDE (40 mg/1)
Marketing started20170530
Package count1

External sources

Source: openFDA. Public-domain (CC0).